EP 1841417 A2 20071010 - SPM 927 FOR ADD-ON THERAPY OF SCHIZOPHRENIA
Title (en)
SPM 927 FOR ADD-ON THERAPY OF SCHIZOPHRENIA
Title (de)
SPM 927 FÜR ADD-ON-THERAPIE VON SCHIZOPHRENIE
Title (fr)
SPM 927 POUR LA THÉRAPIE ADJUVANTE DE LA SCHIZOPHRENIE
Publication
Application
Priority
- EP 2006000722 W 20060127
- EP 05001843 A 20050128
- US 64741005 P 20050128
Abstract (en)
[origin: WO2006079547A2] The present invention is directed to the use of a class of peptide compounds for the prevention, alleviation or/and treatment of a disease that is treated with antipsychotics, in particular psychosis, more particular schizophrenia, in an add-on therapy to at least one antipsychotic.
IPC 8 full level
A61K 31/165 (2006.01); A61P 25/18 (2006.01)
CPC (source: EP KR)
A61K 31/137 (2013.01 - KR); A61K 31/165 (2013.01 - EP KR); A61K 45/06 (2013.01 - EP); A61P 25/00 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2006079547A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK YU
DOCDB simple family (publication)
WO 2006079547 A2 20060803; WO 2006079547 A3 20060921; AR 057643 A1 20071212; AU 2006208630 A1 20060803; AU 2006208630 B2 20110929; BR PI0607043 A2 20090804; CA 2595330 A1 20060803; EA 015566 B1 20111031; EA 200701594 A1 20080228; EP 1841417 A2 20071010; IL 183973 A0 20081229; JP 2008528532 A 20080731; KR 20070096058 A 20071001; MX 2007009070 A 20070912; NO 20074361 L 20071026
DOCDB simple family (application)
EP 2006000722 W 20060127; AR P060100304 A 20060127; AU 2006208630 A 20060127; BR PI0607043 A 20060127; CA 2595330 A 20060127; EA 200701594 A 20060127; EP 06706448 A 20060127; IL 18397307 A 20070614; JP 2007552583 A 20060127; KR 20077019581 A 20070827; MX 2007009070 A 20060127; NO 20074361 A 20070827